Cargando…

Cold Atmospheric Plasma Modification of Amyloid β

Cold atmospheric plasma (CAP) has attracted much attention in the fields of biotechnology and medicine owing to its potential utility in clinical applications. Recently accumulating evidence has demonstrated that CAP influences protein structures. However, there remain open questions regarding the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Yagi-Utsumi, Maho, Tanaka, Tomohiro, Otsubo, Yoko, Yamashita, Akira, Yoshimura, Shinji, Nishida, Motohiro, Kato, Koichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003251/
https://www.ncbi.nlm.nih.gov/pubmed/33803786
http://dx.doi.org/10.3390/ijms22063116
_version_ 1783671645759602688
author Yagi-Utsumi, Maho
Tanaka, Tomohiro
Otsubo, Yoko
Yamashita, Akira
Yoshimura, Shinji
Nishida, Motohiro
Kato, Koichi
author_facet Yagi-Utsumi, Maho
Tanaka, Tomohiro
Otsubo, Yoko
Yamashita, Akira
Yoshimura, Shinji
Nishida, Motohiro
Kato, Koichi
author_sort Yagi-Utsumi, Maho
collection PubMed
description Cold atmospheric plasma (CAP) has attracted much attention in the fields of biotechnology and medicine owing to its potential utility in clinical applications. Recently accumulating evidence has demonstrated that CAP influences protein structures. However, there remain open questions regarding the molecular mechanisms behind the CAP-induced structural perturbations of biomacromolecules. Here, we investigated the potential effects of CAP irradiation of amyloid β (Aβ), an amyloidogenic protein associated with Alzheimer’s disease. Using nuclear magnetic resonance spectroscopy, we observed gradual spectral changes in Aβ after a 10 s CAP pretreatment, which also suppressed its fibril formation, as revealed by thioflavin T assay. As per mass spectrometric analyses, these effects were attributed to selective oxidation of the methionine residue (Met) at position 35. Interestingly, this modification occurred when Aβ was dissolved into a pre-irradiated buffer, indicating that some reactive species oxidize the Met residue. Our results strongly suggest that the H(2)O(2) generated in the solution by CAP irradiation is responsible for Met oxidation, which inhibits Aβ amyloid formation. The findings of the present study provide fundamental insights into plasma biology, giving clues for developing novel applications of CAP.
format Online
Article
Text
id pubmed-8003251
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-80032512021-03-28 Cold Atmospheric Plasma Modification of Amyloid β Yagi-Utsumi, Maho Tanaka, Tomohiro Otsubo, Yoko Yamashita, Akira Yoshimura, Shinji Nishida, Motohiro Kato, Koichi Int J Mol Sci Article Cold atmospheric plasma (CAP) has attracted much attention in the fields of biotechnology and medicine owing to its potential utility in clinical applications. Recently accumulating evidence has demonstrated that CAP influences protein structures. However, there remain open questions regarding the molecular mechanisms behind the CAP-induced structural perturbations of biomacromolecules. Here, we investigated the potential effects of CAP irradiation of amyloid β (Aβ), an amyloidogenic protein associated with Alzheimer’s disease. Using nuclear magnetic resonance spectroscopy, we observed gradual spectral changes in Aβ after a 10 s CAP pretreatment, which also suppressed its fibril formation, as revealed by thioflavin T assay. As per mass spectrometric analyses, these effects were attributed to selective oxidation of the methionine residue (Met) at position 35. Interestingly, this modification occurred when Aβ was dissolved into a pre-irradiated buffer, indicating that some reactive species oxidize the Met residue. Our results strongly suggest that the H(2)O(2) generated in the solution by CAP irradiation is responsible for Met oxidation, which inhibits Aβ amyloid formation. The findings of the present study provide fundamental insights into plasma biology, giving clues for developing novel applications of CAP. MDPI 2021-03-18 /pmc/articles/PMC8003251/ /pubmed/33803786 http://dx.doi.org/10.3390/ijms22063116 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yagi-Utsumi, Maho
Tanaka, Tomohiro
Otsubo, Yoko
Yamashita, Akira
Yoshimura, Shinji
Nishida, Motohiro
Kato, Koichi
Cold Atmospheric Plasma Modification of Amyloid β
title Cold Atmospheric Plasma Modification of Amyloid β
title_full Cold Atmospheric Plasma Modification of Amyloid β
title_fullStr Cold Atmospheric Plasma Modification of Amyloid β
title_full_unstemmed Cold Atmospheric Plasma Modification of Amyloid β
title_short Cold Atmospheric Plasma Modification of Amyloid β
title_sort cold atmospheric plasma modification of amyloid β
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003251/
https://www.ncbi.nlm.nih.gov/pubmed/33803786
http://dx.doi.org/10.3390/ijms22063116
work_keys_str_mv AT yagiutsumimaho coldatmosphericplasmamodificationofamyloidb
AT tanakatomohiro coldatmosphericplasmamodificationofamyloidb
AT otsuboyoko coldatmosphericplasmamodificationofamyloidb
AT yamashitaakira coldatmosphericplasmamodificationofamyloidb
AT yoshimurashinji coldatmosphericplasmamodificationofamyloidb
AT nishidamotohiro coldatmosphericplasmamodificationofamyloidb
AT katokoichi coldatmosphericplasmamodificationofamyloidb